Diagnosis of chronic phase CML (CP-CML) which is mainly based on the detection of the BCR::ABL1 rearrangement remained unchanged, while the diagnostic criteria for AP and BP have been simplified by the ICC CML working group. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.